跳至主要内容
临床试验/NCT03722940
NCT03722940已完成4 期

Combination of Magnesium Sulphate With Total Intravenous Anesthesia Optimized Surgical Field in Pediatric Cochlear Implant Surgery

Wahba bakhet0 个研究点目标入组 66 人开始时间: 2014年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
66
主要终点
Quality of surgical field

研究概览

简要总结

To determine the efficiency of addition of magnesium sulfate to total intravenous anesthesia (TIVA) in optimizing the surgical field during pediatric cochlear implant surgery. Also its effects on the intraoperative evoked stapedial reflex thresholds (ESRT) and the intraoperative anesthetic requirements were evaluated.

详细描述

Sixty-six ASA I and II children (1-6 years) undergoing cochlear implantation under general anesthesia were enrolled in this double blind, randomized study. Children were randomly allocated into two equal groups. Children in Group M (magnesium sulphate group) received an iv bolus dose of magnesium sulfate 40 mg Kg-1 over 5 minutes before induction of anesthesia followed by 15mg Kg-1 h-1 infusion until the start of skin closure. Children in Group C (Control group) received equivalent volumes of isotonic saline solution over the same period instead of magnesium sulphate. Haemodynamic variables, quality of surgical field, ESRT and the intraoperative anesthetic requirements were recorded

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • ASA I and II children

排除标准

  • uncontrolled hypertension,
  • diabetes mellitus,
  • liver disease,
  • kidney disease,
  • heart disease,
  • allergy to magnesium sulphate,

研究组 & 干预措施

Magnesium sulphate

Active Comparator

Group M

干预措施: Magnesium sulphate (Drug)

Na CL 0.9%

Placebo Comparator

group C

干预措施: Na CL 0.9% (Other)

结局指标

主要结局

Quality of surgical field

时间窗: at the end of the surgey

using Fromme's-Boezaart scale (0 to 5). A score of ≤ 2 was considered to be optimal

次要结局

  • The operative time(Intraoperative)
  • ESRT responses(After insertion of the electrode and after reversal of any residual muscle relaxant (TOF response > 0.9),)
  • Heart rate(baseline, after surgical incision, Hypotensive period, after LMA removal and at recovery room admission.)
  • The anesthesia time.(Intraoperative)
  • Mean arterial blood pressure(Intraoperative)
  • Anesthetic consumption(Intraoperative)

研究者

发起方
Wahba bakhet
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wahba bakhet

Lectrure of anesthesia

Ain Shams University

相似试验

Role of Magnesium in Pediatric Cochlear Implant | 临床试验